BMTBiomaterials TranslationalTBA2096-112XBiomaterials Translational10.12336/biomatertransl.2022.03.002ReviewMesenchymal stem cell–derived extracellular vesicles: a possible therapeutic strategy for orthopaedic diseases: a narrative reviewhttps://artdesignp.com/journal/BMT/3/3/10.12336/biomatertransl.2022.03.002ZengZhao–Lin,XieHui2022332022-09-28Accumulating evidence suggests that the therapeutic role of mesenchymal stem cells (MSCs) in bone diseases is closely related to paracrine–generated extracellular vesicles (EVs). MSC–derived EVs (MSC–EVs) carry proteins, nucleic acids, and lipids to the extracellular space and affect the bone microenvironment. They have similar biological functions to MSCs, such as the ability to repair organ and tissue damage. In addition, MSC–EVs also have the advantages of long half–life, low immunogenicity, attractive stability, ability to pass through the blood–brain barrier, and demonstrate excellent performance with potential practical applications in bone diseases. In this review, we summarise the current applications and mechanisms of MSC–EVs in osteoporosis, osteoarthritis, bone tumours, osteonecrosis of the femoral head, and fractures, as well as the development of MSC–EVs combined with materials science in the field of orthopaedics. Additionally, we explore the critical challenges involved in the clinical application of MSC–EVs in orthopaedic diseases.exosomes, extracellular vesicles, mesenchymal stem cells, orthopaedic diseases, regenerative medicine

1. Han, Y.; You, X.; Xing, W.; Zhang, Z.; Zou, W. Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts. Bone Res. 2018, 6, 16.2. Kasza, K.; Gurnani, P.; Hardie, K. R.; Cámara, M.; Alexander, C. Challenges and solutions in polymer drug delivery for bacterial biofilm treatment: a tissue-by-tissue account. Adv Drug Deliv Rev. 2021, 178, 113973.3. Yao, D.; Huang, L.; Ke, J.; Zhang, M.; Xiao, Q.; Zhu, X. Bone metabolism regulation: implications for the treatment of bone diseases. Biomed Pharmacother. 2020, 129, 110494.4. Rachner, T. D.; Khosla, S.; Hofbauer, L. C. Osteoporosis: now and the future. Lancet. 2011, 377, 1276-1287.5. Zhou, W.; Shi, Y.; Wang, H.; Yu, C.; Zhu, H.; Wu, A. Sinensetin reduces osteoarthritis pathology in the tert-butyl hydroperoxide-treated chondrocytes and the destabilization of the medial meniscus model mice via the AMPK/mTOR signaling pathway. Front Pharmacol. 2021, 12, 713491.6. Ullah, I.; Subbarao, R. B.; Rho, G. J. Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015, 35, e00191.7. Uccelli, A.; Moretta, L.; Pistoia, V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008, 8, 726-736.8. Zhou, T.; Yuan, Z.; Weng, J.; Pei, D.; Du, X.; He, C.; Lai, P. Challenges and advances in clinical applications of mesenchymal stromal cells. J Hematol Oncol. 2021, 14, 24.9. Murphy, M. B.; Moncivais, K.; Caplan, A. I. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med. 2013, 45, e54.10. Ankrum, J. A.; Ong, J. F.; Karp, J. M. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol. 2014, 32, 252-260.11. Triffitt, J. T.; Wang, Q. Stem cell fate and microenvironment. Biomater Transl. 2022, 3, 1-2.12. Zeng, Z. L.; Yuan, Q.; Zu, X.; Liu, J. Insights into the role of mitochondria in vascular calcification. Front Cardiovasc Med. 2022, 9, 879752.13. Yáñez-Mó, M.; Siljander, P. R.; Andreu, Z.; Zavec, A. B.; Borràs, F. E.; Buzas, E. I.; Buzas, K.; Casal, E.; Cappello, F.; Carvalho, J.; Colás, E.; Cordeiro-da Silva, A.; Fais, S.; Falcon-Perez, J. M.; Ghobrial, I. M.; Giebel, B.; Gimona, M.; Graner, M.; Gursel, I.; Gursel, M.; Heegaard, N. H.; Hendrix, A.; Kierulf, P.; Kokubun, K.; Kosanovic, M.; Kralj-Iglic, V.; Krämer-Albers, E. M.; Laitinen, S.; Lässer, C.; Lener, T.; Ligeti, E.; Linē, A.; Lipps, G.; Llorente, A.; Lötvall, J.; Manček-Keber, M.; Marcilla, A.; Mittelbrunn, M.; Nazarenko, I.; Nolte-’t Hoen, E. N.; Nyman, T. A.; O’Driscoll, L.; Olivan, M.; Oliveira, C.; Pállinger, É.; Del Portillo, H. A.; Reventós, J.; Rigau, M.; Rohde, E.; Sammar, M.; Sánchez-Madrid, F.; Santarém, N.; Schallmoser, K.; Ostenfeld, M. S.; Stoorvogel, W.; Stukelj, R.; Van der Grein, S. G.; Vasconcelos, M. H.; Wauben, M. H.; De Wever, O. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015, 4, 27066.14. Liu, S.; Xu, X.; Liang, S.; Chen, Z.; Zhang, Y.; Qian, A.; Hu, L. The application of MSCs-derived extracellular vesicles in bone disorders: novel cell-free therapeutic strategy. Front Cell Dev Biol. 2020, 8, 619.15. Mousaei Ghasroldasht, M.; Seok, J.; Park, H. S.; Liakath Ali, F. B.; Al-Hendy, A. Stem cell therapy: from idea to clinical practice. Int J Mol Sci. 2022, 23, 2850.16. Nazari, H.; Zhang, L.; Zhu, D.; Chader, G. J.; Falabella, P.; Stefanini, F.; Rowland, T.; Clegg, D. O.; Kashani, A. H.; Hinton, D. R.; Humayun, M. S. Stem cell based therapies for age-related macular degeneration: the promises and the challenges. Prog Retin Eye Res. 2015, 48, 1-39.17. Ambrosi, T. H.; Longaker, M. T.; Chan, C. K. F. A revised perspective of skeletal stem cell biology. Front Cell Dev Biol. 2019, 7, 189.18. Zeng, Z. L.; Lin, X. L.; Tan, L. L.; Liu, Y. M.; Qu, K.; Wang, Z. MicroRNAs: important regulators of induced pluripotent stem cell generation and differentiation. Stem Cell Rev Rep. 2018, 14, 71-81.19. Jin, J. Stem cell treatments. JAMA. 2017, 317, 330.20. Friedenstein, A. J.; Piatetzky, S., II; Petrakova, K. V. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol. 1966, 16, 381-390.21. Caplan, A. I. Mesenchymal stem cells. J Orthop Res. 1991, 9, 641-650.22. Sacchetti, B.; Funari, A.; Michienzi, S.; Di Cesare, S.; Piersanti, S.; Saggio, I.; Tagliafico, E.; Ferrari, S.; Robey, P. G.; Riminucci, M.; Bianco, P. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell. 2007, 131, 324-336.23. Lukomska, B.; Stanaszek, L.; Zuba-Surma, E.; Legosz, P.; Sarzynska, S.; Drela, K. Challenges and controversies in human mesenchymal stem cell therapy. Stem Cells Int. 2019, 2019, 9628536.24. Huang, Y.; Yang, L. Mesenchymal stem cells and extracellular vesicles in therapy against kidney diseases. Stem Cell Res Ther. 2021, 12, 219.25. Boulanger, C. M.; Loyer, X.; Rautou, P. E.; Amabile, N. Extracellular vesicles in coronary artery disease. Nat Rev Cardiol. 2017, 14, 259-272.26. Harding, C. V.; Heuser, J. E.; Stahl, P. D. Exosomes: looking back three decades and into the future. J Cell Biol. 2013, 200, 367-371.27. Johnstone, R. M.; Adam, M.; Hammond, J. R.; Orr, L.; Turbide, C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987, 262, 9412-9420.28. Théry, C.; Zitvogel, L.; Amigorena, S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002, 2, 569-579.29. Quiñones-Vico, M. I.; Sanabria-de la Torre, R.; Sánchez-Díaz, M.; Sierra-Sánchez, Á.; Montero-Vílchez, T.; Fernández-González, A.; Arias-Santiago, S. The role of exosomes derived from mesenchymal stromal cells in dermatology. Front Cell Dev Biol. 2021, 9, 647012. 30. Ruan, Z.; Pathak, D.; Venkatesan Kalavai, S.; Yoshii-Kitahara, A.;  Muraoka, S.; Bhatt, N.; Takamatsu-Yukawa, K.; Hu, J.; Wang, Y.;  Hersh, S.; Ericsson, M.; Gorantla, S.; Gendelman, H. E.; Kayed, R.;  Ikezu, S.; Luebke, J. I.; Ikezu, T. Alzheimer’s disease brain-derived  extracellular vesicles spread tau pathology in interneurons. Brain. 2021,144, 288-309 31. Maas, S. L. N.; Breakefield, X. O.; Weaver, A. M. Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell Biol. 2017, 27, 172-188.  32. Akers, J. C.; Gonda, D.; Kim, R.; Carter, B. S.; Chen, C. C. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol. 2013, 113, 1-11.  33. Chotiyarnwong, P.; McCloskey, E. V. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment. Nat Rev Endocrinol. 2020, 16, 437-447.  34. Pittenger, M. F.; Mackay, A. M.; Beck, S. C.; Jaiswal, R. K.; Douglas, R.; Mosca, J. D.; Moorman, M. A.; Simonetti, D. W.; Craig, S.; Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science. 1999, 284, 143-147.  35. Takayanagi, H. Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol. 2009, 5, 667-676.  36. Feng, X.; Teitelbaum, S. L. Osteoclasts: new insights. Bone Res. 2013, 1, 11-26.  37. Al-Bari, A. A.; Al Mamun, A. Current advances in regulation of bone homeostasis. FASEB Bioadv. 2020, 2, 668-679.  38. Wu, J.; Zhang, W.; Ran, Q.; Xiang, Y.; Zhong, J. F.; Li, S. C.; Li, Z. The differentiation balance of bone marrow mesenchymal stem cells is crucial to hematopoiesis. Stem Cells Int. 2018, 2018, 1540148.  39. Chen, G.; Zhuo, Y.; Tao, B.; Liu, Q.; Shang, W.; Li, Y.; Wang, Y.; Li, Y.; Zhang, L.; Fang, Y.; Zhang, X.; Fang, Z.; Yu, Y. Moderate SMFs attenuate bone loss in mice by promoting directional osteogenic differentiation of BMSCs. Stem Cell Res Ther. 2020, 11, 487.  40. Du, G.; Cheng, X.; Zhang, Z.; Han, L.; Wu, K.; Li, Y.; Lin, X. TGF-beta induced key genes of osteogenic and adipogenic differentiation in human mesenchymal stem cells and miRNA-mRNA regulatory networks. Front Genet. 2021, 12, 759596.  41. Meyer, M. B.; Benkusky, N. A.; Sen, B.; Rubin, J.; Pike, J. W. Epigenetic plasticity drives adipogenic and osteogenic differentiation of marrow-derived mesenchymal stem cells. J Biol Chem. 2016, 291, 17829-17847.  42. Robert, A. W.; Marcon, B. H.; Dallagiovanna, B.; Shigunov, P. Adipogenesis, osteogenesis, and chondrogenesis of human mesenchymal stem/stromal cells: a comparative transcriptome approach. Front Cell Dev Biol. 2020, 8, 561.  43. Kolf, C. M.; Cho, E.; Tuan, R. S. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther. 2007, 9, 204.  44. Yang, X.; Yang, J.; Lei, P.; Wen, T. LncRNA MALAT1 shuttled by bone marrow-derived mesenchymal stem cells-secreted exosomes alleviates osteoporosis through mediating microRNA-34c/SATB2 axis. Aging (Albany N Y). 2019, 11, 8777-8791.  45. Qiu, M.; Zhai, S.; Fu, Q.; Liu, D. Bone marrow mesenchymal stem cells-derived exosomal microRNA-150-3p promotes osteoblast proliferation and differentiation in osteoporosis. Hum Gene Ther. 2021, 32, 717-729.  46. Huang, B.; Su, Y.; Shen, E.; Song, M.; Liu, D.; Qi, H. Extracellular vesicles from GPNMB-modified bone marrow mesenchymal stem cells attenuate bone loss in an ovariectomized rat model. Life Sci. 2021, 272, 119208.  47. Hu, Y.; Li, X.; Zhang, Q.; Gu, Z.; Luo, Y.; Guo, J.; Wang, X.; Jing, Y.; Chen, X.; Su, J. Exosome-guided bone targeted delivery of Antagomir-188 as an anabolic therapy for bone loss. Bioact Mater. 2021, 6, 2905-2913.  48. Wang, X.; Li, X.; Li, J.; Zhai, L.; Liu, D.; Abdurahman, A.; Zhang, Y.; Yokota, H.; Zhang, P. Mechanical loading stimulates bone angiogenesis through enhancing type H vessel formation and downregulating exosomal miR-214-3p from bone marrow-derived mesenchymal stem cells. FASEB J. 2021, 35, e21150.  49. Bond, J.; Adams, S.; Richards, S.; Vora, A.; Mitchell, C.; Goulden, N. Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia. Blood. 2011, 118, 2632-2633.  50. Li, L.; Wang, Y.; Yu, X.; Bao, Y.; An, L.; Wei, X.; Yu, W.; Liu, B.; Li, J.; Yang, J.; Xia, Y.; Liu, G.; Cao, F.; Zhang, X.; Zhao, D. Bone marrow mesenchymal stem cell-derived exosomes promote plasminogen activator inhibitor 1 expression in vascular cells in the local microenvironment during rabbit osteonecrosis of the femoral head. Stem Cell Res Ther. 2020, 11, 480.  51. Liao, W.; Ning, Y.; Xu, H. J.; Zou, W. Z.; Hu, J.; Liu, X. Z.; Yang, Y.; Li, Z. H. BMSC-derived exosomes carrying microRNA-122-5p promote proliferation of osteoblasts in osteonecrosis of the femoral head. Clin Sci (Lond). 2019, 133, 1955-1975.  52. Kuang, M. J.; Huang, Y.; Zhao, X. G.; Zhang, R.; Ma, J. X.; Wang, D. C.; Ma, X. L. Exosomes derived from Wharton’s jelly of human umbilical cord mesenchymal stem cells reduce osteocyte apoptosis in glucocorticoid-induced osteonecrosis of the femoral head in rats via the miR-21-PTEN-AKT signalling pathway. Int J Biol Sci. 2019, 15, 1861-1871.  53. Tao, S. C.; Yuan, T.; Zhang, Y. L.; Yin, W. J.; Guo, S. C.; Zhang, C. Q. Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics. 2017, 7, 180-195.  54. Tofiño-Vian, M.; Guillén, M. I.; Pérez Del Caz, M. D.; Silvestre, A.; Alcaraz, M. J. Microvesicles from human adipose tissue-derived mesenchymal stem cells as a new protective strategy in osteoarthritic chondrocytes. Cell Physiol Biochem. 2018, 47, 11-25.  55. Wu, J.; Kuang, L.; Chen, C.; Yang, J.; Zeng, W. N.; Li, T.; Chen, H.; Huang, S.; Fu, Z.; Li, J.; Liu, R.; Ni, Z.; Chen, L.; Yang, L. miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis. Biomaterials. 2019, 206, 87-100.  56. Wang, Y.; Chu, Y.; Li, K.; Zhang, G.; Guo, Z.; Wu, X.; Qiu, C.; Li, Y.; Wan, X.; Sui, J.; Zhang, D.; Xiang, H.; Chen, B. Exosomes secreted by adipose-derived mesenchymal stem cells foster metastasis and osteosarcoma proliferation by increasing COLGALT2 expression. Front Cell Dev Biol. 2020, 8, 353.  57. Vallabhaneni, K. C.; Hassler, M. Y.; Abraham, A.; Whitt, J.; Mo, Y. Y.; Atfi, A.; Pochampally, R. Mesenchymal stem/stromal cells under stress increase osteosarcoma migration and apoptosis resistance via extracellular vesicle mediated communication. PLoS One. 2016, 11, e0166027.  58. Li, F.; Chen, X.; Shang, C.; Ying, Q.; Zhou, X.; Zhu, R.; Lu, H.; Hao, X.; Dong, Q.; Jiang, Z. Bone marrow mesenchymal stem cells-derived extracellular vesicles promote proliferation, invasion and migration of osteosarcoma cells via the lncRNA MALAT1/miR-143/NRSN2/Wnt/β-catenin axis. Onco Targets Ther. 2021, 14, 737-749.  59. Zhang, H.; Wang, J.; Ren, T.; Huang, Y.; Liang, X.; Yu, Y.; Wang, W.; Niu, J.; Guo, W. Bone marrow mesenchymal stem cell-derived exosomal miR-206 inhibits osteosarcoma progression by targeting TRA2B. Cancer Lett. 2020, 490, 54-65. 60. Hu, H.; Wang, D.; Li, L.; Yin, H.; He, G.; Zhang, Y. Role of microRNA-335 carried by bone marrow mesenchymal stem cells-derived extracellular vesicles in bone fracture recovery. Cell Death Dis. 2021, 12, 156.61. Katakawa, Y.; Funaba, M.; Murakami, M. Smad8/9 is regulated through the BMP pathway. J Cell Biochem. 2016, 117, 1788-1796.62. Xu, T.; Luo, Y.; Wang, J.; Zhang, N.; Gu, C.; Li, L.; Qian, D.; Cai, W.; Fan, J.; Yin, G. Exosomal miRNA-128-3p from mesenchymal stem cells of aged rats regulates osteogenesis and bone fracture healing by targeting Smad5. J Nanobiotechnology. 2020, 18, 47.63. Liu, W.; Li, L.; Rong, Y.; Qian, D.; Chen, J.; Zhou, Z.; Luo, Y.; Jiang, D.; Cheng, L.; Zhao, S.; Kong, F.; Wang, J.; Zhou, Z.; Xu, T.; Gong, F.; Huang, Y.; Gu, C.; Zhao, X.; Bai, J.; Wang, F.; Zhao, W.; Zhang, L.; Li, X.; Yin, G.; Fan, J.; Cai, W. Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126. Acta Biomater. 2020, 103, 196-212.64. Anam, A. K.; Insogna, K. Update on osteoporosis screening and management. Med Clin North Am. 2021, 105, 1117-1134.65. He, X. Y.; Yu, H. M.; Lin, S.; Li, Y. Z. Advances in the application of mesenchymal stem cells, exosomes, biomimetic materials, and 3D printing in osteoporosis treatment. Cell Mol Biol Lett. 2021, 26, 47.66. Liu, P.; Wang, W.; Li, Z.; Li, Y.; Yu, X.; Tu, J.; Zhang, Z. Ferroptosis: a new regulatory mechanism in osteoporosis. Oxid Med Cell Longev. 2022, 2022, 2634431.67. Li, Y.; Jin, D.; Xie, W.; Wen, L.; Chen, W.; Xu, J.; Ding, J.; Ren, D.; Xiao, Z. Mesenchymal stem cells-derived exosomes: a possible therapeutic strategy for osteoporosis. Curr Stem Cell Res Ther. 2018, 13, 362-368.68. An, Q.; Wu, D.; Ma, Y.; Zhou, B.; Liu, Q. Suppression of Evi1 promotes the osteogenic differentiation and inhibits the adipogenic differentiation of bone marrow-derived mesenchymal stem cells in vitro. Int J Mol Med. 2015, 36, 1615-1622. 69. Wang, Z. X.; Luo, Z. W.; Li, F. X.; Cao, J.; Rao, S. S.; Liu, Y. W.; Wang, Y. Y.; Zhu, G. Q.; Gong, J. S.; Zou, J. T.; Wang, Q.; Tan, Y. J.; Zhang, Y.; Hu, Y.; Li, Y. Y.; Yin, H.; Wang, X. K.; He, Z. H.; Ren, L.; Liu, Z. Z.; Hu, X. K.; Yuan, L. Q.; Xu, R.; Chen, C. Y.; Xie, H. Aged bone matrix-derived extracellular vesicles as a messenger for calcification paradox. Nat Commun. 2022, 13, 1453.  70. Murali, V. P.; Holmes, C. A. Mesenchymal stromal cell-derived extracellular vesicles for bone regeneration therapy. Bone Reports. 2021, 14, 101093.  71. Meng, F.; Xue, X.; Yin, Z.; Gao, F.; Wang, X.; Geng, Z. Research progress of exosomes in bone diseases: mechanism, diagnosis and therapy. Front Bioeng Biotechnol. 2022, 10, 866627.  72. Peng, Y.; Wu, S.; Li, Y.; Crane, J. L. Type H blood vessels in bone modeling and remodeling. Theranostics. 2020, 10, 426-436.  73. Xie, H.; Cui, Z.; Wang, L.; Xia, Z.; Hu, Y.; Xian, L.; Li, C.; Xie, L.; Crane, J.; Wan, M.; Zhen, G.; Bian, Q.; Yu, B.; Chang, W.; Qiu, T.; Pickarski, M.; Duong, L. T.; Windle, J. J.; Luo, X.; Liao, E.; Cao, X. PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat Med. 2014, 20, 1270-1278.  74. Zhang, Y.; Cao, X.; Li, P.; Fan, Y.; Zhang, L.; Ma, X.; Sun, R.; Liu, Y.; Li, W. microRNA-935-modified bone marrow mesenchymal stem cells-derived exosomes enhance osteoblast proliferation and differentiation in osteoporotic rats. Life Sci. 2021, 272, 119204.  75. Yang, Z.; Liu, X.; Zhao, F.; Yao, M.; Lin, Z.; Yang, Z.; Liu, C.; Liu, Y.; Chen, X.; Du, C. Bioactive glass nanoparticles inhibit osteoclast differentiation and osteoporotic bone loss by activating lncRNA NRON expression in the extracellular vesicles derived from bone marrow mesenchymal stem cells. Biomaterials. 2022, 283, 121438.  76. Lai, C. P.; Mardini, O.; Ericsson, M.; Prabhakar, S.; Maguire, C.; Chen, J. W.; Tannous, B. A.; Breakefield, X. O. Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. ACS Nano. 2014, 8, 483-494.  77. Elsharkasy, O. M.; Nordin, J. Z.; Hagey, D. W.; de Jong, O. G.; Schiffelers, R. M.; Andaloussi, S. E.; Vader, P. Extracellular vesicles as drug delivery systems: why and how? Adv Drug Deliv Rev. 2020, 159, 332-343.  78. Luo, Z. W.; Li, F. X.; Liu, Y. W.; Rao, S. S.; Yin, H.; Huang, J.; Chen, C. Y.; Hu, Y.; Zhang, Y.; Tan, Y. J.; Yuan, L. Q.; Chen, T. H.; Liu, H. M.; Cao, J.; Liu, Z. Z.; Wang, Z. X.; Xie, H. Aptamer-functionalized exosomes from bone marrow stromal cells target bone to promote bone regeneration. Nanoscale. 2019, 11, 20884-20892.  79. Cui, Y.; Guo, Y.; Kong, L.; Shi, J.; Liu, P.; Li, R.; Geng, Y.; Gao, W.; Zhang, Z.; Fu, D. A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis. Bioact Mater. 2022, 10, 207-221.  80. Petek, D.; Hannouche, D.; Suva, D. Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment. EFORT Open Rev. 2019, 4, 85-97.  81. Baig, S. A.; Baig, M. N. Osteonecrosis of the femoral head: etiology, investigations, and management. Cureus. 2018, 10, e3171.  82. Zhang, C.; Su, Y.; Ding, H.; Yin, J.; Zhu, Z.; Song, W. Mesenchymal stem cells-derived and siRNAs-encapsulated exosomes inhibit osteonecrosis of the femoral head. J Cell Mol Med. 2020, 24, 9605-9612.  83. Guilak, F.; Nims, R. J.; Dicks, A.; Wu, C. L.; Meulenbelt, I. Osteoarthritis as a disease of the cartilage pericellular matrix. Matrix Biol. 2018, 71-72, 40-50.  84. Roos, E. M.; Arden, N. K. Strategies for the prevention of knee osteoarthritis. Nat Rev Rheumatol. 2016, 12, 92-101.  85. Mianehsaz, E.; Mirzaei, H. R.; Mahjoubin-Tehran, M.; Rezaee, A.; Sahebnasagh, R.; Pourhanifeh, M. H.; Mirzaei, H.; Hamblin, M. R. Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis? Stem Cell Res Ther. 2019, 10, 340.  86. Zhu, Y.; Wang, Y.; Zhao, B.; Niu, X.; Hu, B.; Li, Q.; Zhang, J.; Ding, J.; Chen, Y.; Wang, Y. Comparison of exosomes secreted by induced pluripotent stem cell-derived mesenchymal stem cells and synovial membrane-derived mesenchymal stem cells for the treatment of osteoarthritis. Stem Cell Res Ther. 2017, 8, 64.  87. Sarhadi, V. K.; Daddali, R.; Seppänen-Kaijansinkko, R. Mesenchymal stem cells and extracellular vesicles in osteosarcoma pathogenesis and therapy. Int J Mol Sci. 2021, 22, 11035.  88. Xu, X.; Qiu, B.; Yi, P.; Li, H. Overexpression of miR-206 in osteosarcoma and its associated molecular mechanisms as assessed through TCGA and GEO databases. Oncol Lett. 2020, 19, 1751-1758.  89. Kempf-Bielack, B.; Bielack, S. S.; Jürgens, H.; Branscheid, D.; Berdel, W. E.; Exner, G. U.; Göbel, U.; Helmke, K.; Jundt, G.; Kabisch, H.; Kevric, M.; Klingebiel, T.; Kotz, R.; Maas, R.; Schwarz, R.; Semik, M.; Treuner, J.; Zoubek, A.; Winkler, K. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol. 2005, 23, 559-568.  90. Zhao, W.; Qin, P.; Zhang, D.; Cui, X.; Gao, J.; Yu, Z.; Chai, Y.; Wang, J.; Li, J. Long non-coding RNA PVT1 encapsulated in bone marrow mesenchymal stem cell-derived exosomes promotes osteosarcoma growth and metastasis by stabilizing ERG and sponging miR-183-5p. Aging (Albany N Y). 2019, 11, 9581-9596. 91. He, H.; Ding, M.; Li, T.; Zhao, W.; Zhang, L.; Yin, P.; Zhang, W. Bone mesenchymal stem cell-derived extracellular vesicles containing NORAD promote osteosarcoma by miR-30c-5p. Lab Invest. 2022. doi:10.1038/s41374-021-00691-6.  92. Einhorn, T. A.; Gerstenfeld, L. C. Fracture healing: mechanisms and interventions. Nat Rev Rheumatol. 2015, 11, 45-54.  93. Komatsu, D. E.; Warden, S. J. The control of fracture healing and its therapeutic targeting: improving upon nature. J Cell Biochem. 2010, 109, 302-311.  94. Buettmann, E. G.; McKenzie, J. A.; Migotsky, N.; Sykes, D. A.; Hu, P.; Yoneda, S.; Silva, M. J. VEGFA from early osteoblast lineage cells (Osterix+) is required in mice for fracture healing. J Bone Miner Res. 2019, 34, 1690-1706.  95. Sun, Y.; Xiong, Y.; Yan, C.; Chen, L.; Chen, D.; Mi, B.; Liu, G. Downregulation of microRNA-16-5p accelerates fracture healing by promoting proliferation and inhibiting apoptosis of osteoblasts in patients with traumatic brain injury. Am J Transl Res. 2019, 11, 4746-4760.  96. Lin, Z.; Xiong, Y.; Meng, W.; Hu, Y.; Chen, L.; Chen, L.; Xue, H.; Panayi, A. C.; Zhou, W.; Sun, Y.; Cao, F.; Liu, G.; Hu, L.; Yan, C.; Xie, X.; Lin, C.; Cai, K.; Feng, Q.; Mi, B.; Liu, G. Exosomal PD-L1 induces osteogenic differentiation and promotes fracture healing by acting as an immunosuppressant. Bioact Mater. 2022, 13, 300-311.  97. Tan, S. H. S.; Wong, J. R. Y.; Sim, S. J. Y.; Tjio, C. K. E.; Wong, K. L.; Chew, J. R. J.; Hui, J. H. P.; Toh, W. S. Mesenchymal stem cell exosomes in bone regenerative strategies-a systematic review of preclinical studies. Mater Today Bio. 2020, 7, 100067.  98. Wang, X.; Thomsen, P. Mesenchymal stem cell-derived small extracellular vesicles and bone regeneration. Basic Clin Pharmacol Toxicol. 2021, 128, 18-36.  99. Zhai, M.; Zhu, Y.; Yang, M.; Mao, C. Human mesenchymal stem cell derived exosomes enhance cell-free bone regeneration by altering their miRNAs profiles. Adv Sci (Weinh). 2020, 7, 2001334.  100. Zhou, X.; Miao, Y.; Wang, Y.; He, S.; Guo, L.; Mao, J.; Chen, M.; Yang, Y.; Zhang, X.; Gan, Y. Tumour-derived extracellular vesicle membrane hybrid lipid nanovesicles enhance siRNA delivery by tumour-homing and intracellular freeway transportation. J Extracell Vesicles. 2022, 11, e12198.  101. Alqurashi, H.; Ortega Asencio, I.; Lambert, D. W. The emerging potential of extracellular vesicles in cell-free tissue engineering and regenerative medicine. Tissue Eng Part B Rev. 2021, 27, 530-538.  102. Xie, H.; Wang, Z.; Zhang, L.; Lei, Q.; Zhao, A.; Wang, H.; Li, Q.; Cao, Y.; Jie Zhang, W.; Chen, Z. Extracellular vesicle-functionalized decalcified bone matrix scaffolds with enhanced pro-angiogenic and pro-bone regeneration activities. Sci Rep. 2017, 7, 45622.  103. Li, W.; Liu, Y.; Zhang, P.; Tang, Y.; Zhou, M.; Jiang, W.; Zhang, X.; Wu, G.; Zhou, Y. Tissue-engineered bone immobilized with human adipose stem cells-derived exosomes promotes bone regeneration. ACS Appl Mater Interfaces. 2018, 10, 5240-5254.  104. Zhang, J.; Liu, X.; Li, H.; Chen, C.; Hu, B.; Niu, X.; Li, Q.; Zhao, B.; Xie, Z.; Wang, Y. Exosomes/tricalcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signaling pathway. Stem Cell Res Ther. 2016, 7, 136.  105. Qi, X.; Zhang, J.; Yuan, H.; Xu, Z.; Li, Q.; Niu, X.; Hu, B.; Wang, Y.; Li, X. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells repair critical-sized bone defects through enhanced angiogenesis and osteogenesis in osteoporotic rats. Int J Biol Sci. 2016, 12, 836-849.  106. Wang, L.; Wang, J.; Zhou, X.; Sun, J.; Zhu, B.; Duan, C.; Chen, P.; Guo, X.; Zhang, T.; Guo, H. A new self-healing hydrogel containing hucMSC-derived exosomes promotes bone regeneration. Front Bioeng Biotechnol. 2020, 8, 564731.  107. Diomede, F.; Gugliandolo, A.; Cardelli, P.; Merciaro, I.; Ettorre, V.; Traini, T.; Bedini, R.; Scionti, D.; Bramanti, A.; Nanci, A.; Caputi, S.; Fontana, A.; Mazzon, E.; Trubiani, O. Three-dimensional printed PLA scaffold and human gingival stem cell-derived extracellular vesicles: a new tool for bone defect repair. Stem Cell Res Ther. 2018, 9, 104.  108. Yang, S.; Zhu, B.; Yin, P.; Zhao, L.; Wang, Y.; Fu, Z.; Dang, R.; Xu, J.; Zhang, J.; Wen, N. Integration of human umbilical cord mesenchymal stem cells-derived exosomes with hydroxyapatite-embedded hyaluronic acid-alginate hydrogel for bone regeneration. ACS Biomater Sci Eng. 2020, 6, 1590-1602.